Daniel Da Costa
About Daniel Da Costa
Daniel Da Costa is an Associate Director and Clinical Scientist at Day One Biopharmaceuticals, where he has worked since 2021. He has extensive experience in clinical science, having previously held positions at AbbVie, Stemcentrx, and Roche.
Current Role at Day One Biopharmaceuticals
Daniel Da Costa serves as the Associate Director and Clinical Scientist at Day One Biopharmaceuticals. He has held this position since 2021, contributing to the company's clinical development efforts in the San Francisco Bay Area. His role involves overseeing clinical research initiatives and collaborating with cross-functional teams to advance therapeutic programs.
Previous Experience at AbbVie
Daniel Da Costa worked at AbbVie in various capacities. He began as a Clinical Scientist II at AbbVie Stemcentrx for five months in 2018. Following this, he served as Associate Scientific Director from 2018 to 2021, where he focused on clinical science and contributed to the development of innovative therapies in the San Francisco Bay Area.
Background in Clinical Science
Before his tenure at AbbVie, Daniel Da Costa gained experience as a Clinical Scientist I at Stemcentrx, Inc. from 2016 to 2018. His career in clinical science began with a post-doctoral fellowship at Roche, where he worked as a Post-Doctoral Fellow in Clinical Science from 2014 to 2016 in New York, NY.
Educational Qualifications
Daniel Da Costa holds a Doctor of Pharmacy (Pharm.D.) from the University of the Pacific. He also completed a post-doctoral fellowship in clinical science and translational medicine at Rutgers University-New Brunswick. Additionally, he earned a Bachelor of Science degree from the University of California, Santa Barbara, where he studied from 2006 to 2010.